Combination Therapies of Hypomethylating Agents for Elderly Patients With Acute Myeloid Leukemia

Acta Haematologica Polonica - Poland
doi 10.2478/ahp-2018-0011
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Walter de Gruyter GmbH

Related search

Emerging Therapies for Acute Myeloid Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2017English

Acute Myeloid Leukemia After Myelodysplastic Syndrome and Failure of Therapy With Hypomethylating Agents: An Emerging Entity With a Poor Prognosis

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2014English

Author Correction: Lineage Tracing of Acute Myeloid Leukemia Reveals the Impact of Hypomethylating Agents on Chemoresistance Selection

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Novel Agents in Acute Myeloid Leukemia

International Journal of Hematology
Hematology
2012English

Effectiveness and Safety of Therapeutic Regimens for Elderly Patients With Acute Myeloid Leukemia: A Systematic Literature Review

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2018English

Antitumor Synergy With SY-1425, a Selective RARα Agonist, and Hypomethylating Agents in Retinoic Acid Receptor Pathway Activated Models of Acute Myeloid Leukemia

Haematologica
Hematology
2018English

Caring an Elderly Patient With Acute Myeloid Leukemia: A Case Study

Hemşirelikte Eğitim ve Araştırma Dergisi
2017English

Novel Therapies for Children With Acute Myeloid Leukaemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2013English

Superior Outcome With Hypomethylating Therapy in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome and Chromosome 5 and 7 Abnormalities

Cancer
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy